GSK, Moderna Settle Patent Dispute Over Moderna COVID, RSV Shots
British drugmaker GSK has settled lawsuits that accused Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Oct. 6. Moderna said in a press release that it settled GSK’s patent litigation …
We haven't written up this one. Insurance Journal has the full story — the link below goes straight to it.